Cell line name |
Hs578T-Dox |
Synonyms |
Hs578T/Doxo |
Accession |
CVCL_IR02 |
Resource Identification Initiative |
To cite this cell line use: Hs578T-Dox (RRID:CVCL_IR02) |
Comments |
Population: Caucasian. Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin). Derived from site: In situ; Breast; UBERON=UBERON_0000310. |
Sequence variations |
- Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
- Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012612; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Homozygous (from parent cell line).
|
Disease |
Invasive breast carcinoma of no special type (NCIt: C4194) |
Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
Hierarchy |
Parent: CVCL_0332 (Hs 578T) |
Sex of cell |
Female |
Age at sampling |
74Y |
Category |
Cancer cell line |
Publications | PubMed=7902062 Manuel de la Torre, Xiao-Yong Hao, Rolf Larsson, Peter Nygren, Takashi Tsuruo, Bengt Mannervik, Jonas Bergh; Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases. Anticancer Res. 13:1425-1430(1993) PubMed=10571255; DOI=10.1016/S0006-2952(99)00262-2 Osten Jonsson, Parviz Behnam-Motlagh, Mattias Persson, Roger Henriksson, Kjell Grankvist; Increase in doxorubicin cytotoxicity by carvedilol inhibition of P-glycoprotein activity. Biochem. Pharmacol. 58:1801-1806(1999) PubMed=15239129; DOI=10.1002/ijc.20300 Chuan-Xi Cai, Jian-Wen Chen; Overexpression of caveolin-1 induces alteration of multidrug resistance in Hs578T breast adenocarcinoma cells. Int. J. Cancer 111:522-529(2004) |
Cross-references |
Cell line databases/resources |
cancercelllines; CVCL_IR02
|
Encyclopedic resources |
Wikidata; Q54896337
|
Entry history |
Entry creation | 03-Mar-2017 |
Last entry update | 19-Dec-2024 |
Version number | 14 |
---|